Chroma Medicine
WEBBuilding on groundbreaking research from the world’s foremost genomic medicine experts, Chroma is developing an entirely new class of therapeutics to achieve unparalleled control of gene expression—all without cutting, nicking, or altering the DNA sequence.
News - Chroma Medicine
WEBRead the latest news and media about Chroma and our epigenetic editing approach to treating genetically driven disease.
Chroma Medicine Demonstrates Robust and Durable HBV …
WEBSep 16, 2024 · In vivo data demonstrated that a single administration of Chroma's epigenetic editor durably silenced HBsAg secretion in AAV-HBV and transgenic (Tg)-HBV mouse models, with dose-dependent ...
Chroma Medicine Strengthens Leadership with the Appointment …
WEBSep 27, 2023 · Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the addition of innovative biotech business leader Michael A....
Chroma Medicine Presents Preclinical In Vivo Data Showing …
WEBNov 11, 2023 · Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented new preclinical data demonstrating that a single administration...
Chroma Medicine Announces Exclusive License Agreement with …
WEBJun 27, 2024 · Chroma Medicine, Inc. (Chroma) a genomic medicine company pioneering single-course epigenetic editing therapeutics, today announced it has entered into an exclusive license agreement with the Whitehead Institute to access intellectual property and technology developed in the lab of Chroma co-founder Jonathan Weissman, Ph.D.
Chroma Medicine Launches with $125M in Financing to Deliver …
WEBCAMBRIDGE, Mass., Nov. 17, 2021 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a new genomic medicine company pioneering epigenetic editing, launched today with $125M in financing. Atlas...
Chroma bags $135M to bolster epigenetic-focused platform
WEBFeb 28, 2023 · Chroma Medicine has tacked on $135 million in fresh financing to bolster its gene-regulating platform, with its preclinical assets still undisclosed.
Chroma Technology Unveils New Website Optimized for …
WEBApr 29, 2024 · Chroma Technology, a leading manufacturer of high-performance optical filters, has launched a redesigned website to provide a best-in-class online experience for the optics and photonics community.
Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing
WEBMar 11, 2023 · With $135 million in new financing, Chroma Medicine plans to present promising proof of concept data for its epigenetic genome editing platform, advance its pipeline, and grow its workforce.
- Some results have been removed